Natural Killer (NK) Cells in Tumor Immunity: Limitations and Therapeutic Potential with a Focus on Nasopharyngeal Carcinoma and Comparison with T-Cell-Based Therapies
Anna Makowska, Udo Kontny · 2026
Read Natural Killer (NK) Cells in Tumor Immunity: Limitations and Therapeutic Potential with a Focus on Nasopharyngeal Carcinoma and Comparison with T-Cell-Based Therapies by Anna Makowska, Udo Kontny (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13204310.txt.
Description
Anna Makowska and Udo Kontny review natural killer cells as a cancer treatment platform in this 2026 paper. These immune cells kill without needing a prior lesson about their target, and they carry a gentler side-effect profile than engineered T cells. The review gives special weight to nasopharyngeal carcinoma, a virus-driven throat cancer.
The authors survey the whole pipeline: cytokine support, donated cell products, engager molecules that lash the cells to tumors, and receptor-armed versions. Trials, mostly in blood cancers, show the approach is safe and active. Weak points remain: the cells fade fast, home poorly, and tumors learn to hide. The throat cancer setting shows both the blocks and the openings clearly.
Catalog record
| CREATOR | Anna Makowska, Udo Kontny |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |